Correlation Between GeneDx Holdings and Co Diagnostics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GeneDx Holdings and Co Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GeneDx Holdings and Co Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GeneDx Holdings Corp and Co Diagnostics, you can compare the effects of market volatilities on GeneDx Holdings and Co Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GeneDx Holdings with a short position of Co Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of GeneDx Holdings and Co Diagnostics.

Diversification Opportunities for GeneDx Holdings and Co Diagnostics

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between GeneDx and CODX is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding GeneDx Holdings Corp and Co Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Co Diagnostics and GeneDx Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GeneDx Holdings Corp are associated (or correlated) with Co Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Co Diagnostics has no effect on the direction of GeneDx Holdings i.e., GeneDx Holdings and Co Diagnostics go up and down completely randomly.

Pair Corralation between GeneDx Holdings and Co Diagnostics

Considering the 90-day investment horizon GeneDx Holdings Corp is expected to generate 2.43 times more return on investment than Co Diagnostics. However, GeneDx Holdings is 2.43 times more volatile than Co Diagnostics. It trades about 0.23 of its potential returns per unit of risk. Co Diagnostics is currently generating about -0.18 per unit of risk. If you would invest  3,073  in GeneDx Holdings Corp on September 2, 2024 and sell it today you would earn a total of  4,766  from holding GeneDx Holdings Corp or generate 155.09% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

GeneDx Holdings Corp  vs.  Co Diagnostics

 Performance 
       Timeline  
GeneDx Holdings Corp 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in GeneDx Holdings Corp are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak technical and fundamental indicators, GeneDx Holdings unveiled solid returns over the last few months and may actually be approaching a breakup point.
Co Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Co Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

GeneDx Holdings and Co Diagnostics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GeneDx Holdings and Co Diagnostics

The main advantage of trading using opposite GeneDx Holdings and Co Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GeneDx Holdings position performs unexpectedly, Co Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Co Diagnostics will offset losses from the drop in Co Diagnostics' long position.
The idea behind GeneDx Holdings Corp and Co Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges